Trial Profile
Metformin and Lorcaserin for Weight Loss in Schizophrenia
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary) ; Metformin
- Indications Overweight
- Focus Therapeutic Use
- Acronyms MELT
- 07 May 2020 Status changed from recruiting to discontinued.
- 28 Sep 2016 Status changed from not yet recruiting to recruiting.
- 25 Jun 2016 New trial record